Immunological aspects of Epstein-Barr virus infection (Q35017852)

5 August 2017

1 reference

title

Immunological aspects of Epstein-Barr virus infection (English)

1 reference

5 August 2017

0 references

Shouichi Ohga

1

1 reference

5 August 2017

Akihiko Nomura

series ordinal

2

1 reference

5 August 2017

Hidetoshi Takada

series ordinal

3

1 reference

5 August 2017

Toshiro Hara

series ordinal

4

1 reference

5 August 2017

1 December 2002

1 reference

Critical Reviews in Oncology Hematology

5 August 2017

1 reference

5 August 2017

44

1 reference

5 August 2017

203-215

1 reference

5 August 2017

3

1 reference

Molecular virology of Epstein-Barr virus

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Post-transplant malignancy: the role of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The chronic mononucleosis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Severe chronic active Epstein-Barr virus infection syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Chronic active Epstein-Barr virus infection in children in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Biology and disease associations of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

A review of Epstein-Barr virus infection in patients with immunodeficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Immunoglobulin A-Induced Shift of Epstein-Barr Virus Tissue Tropism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The ins and outs of EBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus entry into cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The immunology of Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

An Epstein-Barr virus-associated superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

T-cell memory: lessons from Epstein-Barr virus infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The ecology and pathology of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Elevated T cell receptor gamma delta + T cells in patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

A subset of V delta 1+ T cells proliferates in response to Epstein-Barr virus-transformed B cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Cytotoxic gamma delta I lymphocytes associated with an Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Inhibition of tumor necrosis factor-α transcription by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Acute complications of Epstein-Barr virus infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Routine detection of Epstein-Barr virus specific T-cells in the peripheral blood by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus and apoptosis: viral mimicry of cellular pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The primary and memory immune response to Epstein-Barr virus infection in vitro is characterized by a divergent production of IL-1beta/IL-6 and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Viral interleukin-10 in chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

Immunotherapeutic strategies for EBV-associated malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900112-9

7 January 2021

10.1016/S1040-8428(02)00112-9

Identifiers

DOI

1 reference

5 August 2017

1 reference